High Frequency Transport Phasitron Breathing Circuit Kit REF: A50605-D, Rx Only, CE 0123
FDA Device Recall #Z-0637-2024 - Class I, December 12, 2023
Recall Summary
| Recall Number | Z-0637-2024 |
| Classification | Class I - Serious risk |
| Date Initiated | December 12, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Percussionaire Corporation |
| Location | Sandpoint, ID |
| Product Type | Devices |
| Quantity | 2145 units |
Product Description
High Frequency Transport Phasitron Breathing Circuit Kit REF: A50605-D, Rx Only, CE 0123
Reason for Recall
Due to an assembly error within the breathing circuit, their pressure output of the breathing circuit kit can be affected and have severe impact to the end user
Distribution Pattern
US:AL AR CA CT FL GA IL IN KS LA MI MN MO NC NJ OH OR TN TX UT VA OUS: None
Lot / Code Information
UDI: (01)10849436000331/Lot # WO05216, WO05254, WO05321, WO05392, WO05559, WO05588, WO05684, WO05749, WO05896, WO05930,WO06028
Other Recalls from Percussionaire Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0031-2026 | Class I | Phasitron 5, IPV In-Line Valve, (Intrapulmonary... | Sep 17, 2025 |
| Z-0960-2025 | Class I | VDR4 Phasitron Breathing Circuit Models that co... | Dec 23, 2024 |
| Z-0208-2025 | Class I | Phasitron5 Breathing Circuit (P5-10, P5-HC, P5-... | Sep 16, 2024 |
| Z-3208-2024 | Class I | Percussionaire, Inc., REF: P5-TEE-20, Qty: 20,... | Aug 21, 2024 |
| Z-3207-2024 | Class I | Percussionaire, Inc., REF: P5-TEE, Qty: 1, Rx ... | Aug 21, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.